G2023 Insurance Policy Changes

HCPCS G2023 is officially defined as "Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source." HCPCS G2023 is referenced in 3 tracked payer policy changes from Blue Cross Blue Shield of Wyoming and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G2023 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.